Condition: Colorectal Surgery · Readmission · Sponsor: Nantes University Hospital
The goal of this Clinical Investigation is to evaluate the effectiveness of implementing the discharge protocol of the remote monitoring platform after colorectal surgery in patients at risk of hospital readmission. Participants will be randomized into either the "30 days of remote monitoring" group or the "conventional discharge" group. The patient returns to the site for their postoperative visit at 30 days and is contacted by phone 90 days after their surgery.
This description comes directly from the study's public registry record.
Emilie DUCHALAIS · +33 2 40 08 43 22 · emilie.duchalais@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| CHU Angers | Angers, France | Recruiting |
| Clinique Tivoli- Ducos | Bordeaux, France | Recruiting |
| CHU Grenoble | Grenoble, France | Recruiting |
| Centre Hospitalier Lyon-Sud | Lyon, France | Recruiting |
| CHU Timone - Assistance publique-Hôpitaux de Marseille | Marseille, France | Recruiting |
| Hôpital Nord - Assistance publique- Hôpitaux de Marseille | Marseille, France | Recruiting |
| Institut Paoli Calmettes | Marseille, France | Not Yet Recruiting |
| CHU Nantes | Nantes, France | Recruiting |
| Hôpital de Bicêtre - Assistance Publique Hôpitaux de Paris | Paris, France | Recruiting |
| Hôpital Saint Antoine - Assistance publique - Hôpitaux de Paris | Paris, France | Recruiting |
| CHU Rennes | Rennes, France | Recruiting |
| Clinique Mutualiste de l'estuaire | Saint-Nazaire, France | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06850688